• P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

Journal of Pharmaceutical Research

Year: 2019, Volume: 18, Issue: 4, Pages: 12-16

Original Article

Z-Isomer Control in the Synthesis of Flupentixol Related Compounds

Abstract

Flupentixol, a potent antipsychotic and antidepressant, exists in two geometric isomers, Z and E, with the Z-isomer being the therapeutically active form. The synthesis of flupentixol and related compounds often faces the challenge of controlling the stereochemistry to favor the Z-isomer. The study aimed to identify the optimal conditions for producing the Z-isomer, which is more therapeutically relevant. 2-(trifluoromethyl)-9H-thioxanthen-9-one was prepared from 2-mercaptobenzoic acid and perabromobenzotrifluoride, followed by a Grignard rearrangement to form (9-(3-dimethylamino)propyl)-2-(trifluoromethyl)-9,10aH-dihydro-8aH-thioxanthen-9-ol. The intermediate was dehydrated with various acids to produce the E and Z isomers of Flupentixol, with the product ratios subsequently analyzed using ¹H-NMR spectroscopy. The dehydration reactions yielded different E/Z isomer ratios, yields, and melting points, depending on the acid used. Hydrochloric, oxalic, and methanesulfonic acids favored the formation of the Z-isomer with E/Z ratios of 11:89, 14:86, and 12:88, respectively, while succinic acid achieved the highest yield (84.75%) with a 37:63 E/Z ratio. Maleic acid and ferrous sulfate produced intermediate ratios, and DL- and L(+)-tartaric acids gave similar results with high yields. This study revealed a novel insight into the influence of various acids on the dehydration reactions, highlighting specific acids that significantly favor the formation of the therapeutically active Z-isomer of Flupentixol with optimized yields and ratios.

Keywords: Flupentixol, Z­isomer, E­isomer, Antipsychotic drugs, ¹H­NMR, Racemic resolution

References

  1. Adams CE, Fenton MKP, Quraishi S, David AS. Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. British Journal of Psychiatry. 2001;179(4):290–299. Available from: https://dx.doi.org/10.1192/bjp.179.4.290
  2. Addonizio G, Susman VL, Roth SD. Neuroleptic malignant syndrome: review and analysis of 115 cases. Biological Psychiatry. 1987;22(8):1004–1020. Available from: https://dx.doi.org/10.1016/0006-3223(87)90010-2
  3. Raymond B, Neumeyer J. Antipsychotics and Anxiolytic agents. Foyes Principles of Medicinal Chemistry. Philadelphia: Lippincott. 2002;p. 408–433. Available from: https://books.google.co.in/books/about/Foye_s_Principles_of_Medicinal_Chemistry.html?id=qLJ6Bs1Qml4C
  4. Kaiser C, Setler PE. Antipsychotic: Burger’s medicinal chemistry and drug discovery. John Wiley and Sons. New York. 2007;6:485–510.

Copyright

© 2019 Published by Krupanidhi College of Pharmacy. This is an open-access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/

DON'T MISS OUT!

Subscribe now for latest articles and news.